Published in Gynecol Oncol on July 01, 1997
Right trisectionectomy for primary liver cancer. World J Gastroenterol (2003) 0.86
The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma. World J Surg (2011) 0.82
Hematogenous metastases in patients with Stage I or II endometrial carcinoma. Strahlenther Onkol (2011) 0.82
Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer. Cancer Biol Med (2012) 0.80
Surgical resection of recurrent upper abdominal cervical cancer: A case report and review of the literature. Gynecol Oncol Case Rep (2011) 0.80
Hepatic resection for metastatic endometrioid carcinoma. HPB (Oxford) (2010) 0.76
Hepatic resection for metachronous metastases from ovarian carcinoma. HPB (Oxford) (2006) 0.75
Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review. Gynecol Oncol Res Pract (2016) 0.75
Liver recurrence in endometrial cancer: a multi-institutional analysis of factors predictive of postrecurrence survival. Clin Exp Metastasis (2016) 0.75
Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics (2004) 24.18
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (1988) 13.42
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet (1987) 4.18
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med (1988) 4.02
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA (2000) 3.69
Two-stage designs for gene-disease association studies. Biometrics (2002) 3.67
Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet (1988) 3.30
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06
Segment-oriented hepatic resection in the management of malignant neoplasms of the liver. J Am Coll Surg (1998) 3.04
Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg (1998) 2.97
Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg (1998) 2.81
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol (2006) 2.69
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys (2002) 2.65
Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg (2000) 2.60
Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57
Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg (1999) 2.57
Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol (2000) 2.48
A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index. Clin Cancer Res (1998) 2.43
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol (2000) 2.40
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Symptoms of ovarian cancer. Obstet Gynecol (2001) 2.27
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol (2008) 2.12
Two-stage designs for gene-disease association studies with sample size constraints. Biometrics (2004) 2.08
One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg (1994) 2.03
Management of 155 patients with benign liver tumours. Br J Surg (2001) 1.97
BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). Cancer Res (1998) 1.97
Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges. Gynecol Oncol (1999) 1.91
Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg (2000) 1.85
Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J (1989) 1.82
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol (2000) 1.77
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol (1999) 1.75
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol (1993) 1.73
Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys (2000) 1.71
Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg (2001) 1.69
Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68
Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). FASEB J (1999) 1.64
Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol (2003) 1.63
Paclitaxel-based chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol (2001) 1.59
Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem (2000) 1.59
Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model. Stat Med (2000) 1.57
A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer (2001) 1.57
A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg (2000) 1.57
Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial. Gynecol Oncol (1996) 1.55
High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol Oncol (2001) 1.52
Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. Int J Radiat Oncol Biol Phys (2000) 1.50
Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet (1990) 1.50
Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg (2001) 1.49
Stage IV ovarian cancer: impact of surgical debulking. Gynecol Oncol (1997) 1.47
Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size. Stat Med (2007) 1.44
Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol (2001) 1.42
Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer (2000) 1.41
Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg (1995) 1.40
Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys (2001) 1.39
Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. Int J Gynecol Cancer (2007) 1.39
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol (2009) 1.39
The Caenorhabditis elegans maternal-effect sterile proteins, MES-2, MES-3, and MES-6, are associated in a complex in embryos. Proc Natl Acad Sci U S A (2001) 1.32
Cholangiocarcinoma at the hepatic hilus: sonographic findings. AJR Am J Roentgenol (1997) 1.32
Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery (1998) 1.32
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Ann Oncol (2010) 1.31
Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol (2001) 1.28
Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. Ann Surg (1989) 1.27
Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer. Cancer Gene Ther (2006) 1.23
Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon. J Clin Invest (1997) 1.22
Soft-tissue sarcoma of the vagina and vulva: a clinicopathologic study. Obstet Gynecol (1995) 1.21
What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J Am Coll Surg (2001) 1.21
Complete resection of the caudate lobe of the liver: technique and results. Br J Surg (1996) 1.21
Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg (2007) 1.19
Isolated hepatic splenosis: first reported case. HPB Surg (1998) 1.18
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg (1999) 1.18
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer (2008) 1.18
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecol Oncol (2010) 1.17
Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J (1989) 1.17
Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc Natl Acad Sci U S A (1999) 1.15
Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology (1996) 1.14
Natural ceramide reverses Fas resistance of acid sphingomyelinase(-/-) hepatocytes. J Biol Chem (2000) 1.14
Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol (2012) 1.14
A technique for the use of cryosurgery to assist hepatic resection. J Am Coll Surg (1995) 1.13
Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus. J Virol (2001) 1.12
The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol (2003) 1.12
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. Gynecol Oncol (2011) 1.12
Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia (2001) 1.11
Recent advances in hepatic resection. Semin Surg Oncol (2000) 1.11
Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma. Hum Gene Ther (2001) 1.10
Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data. Int J Radiat Oncol Biol Phys (2001) 1.09
Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography. AJR Am J Roentgenol (1998) 1.09
Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg (1995) 1.09
Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer. Nat Med (2001) 1.08
Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg (1997) 1.07
Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg (1998) 1.07
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg (1999) 1.07
Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Ann Surg Oncol (1998) 1.06
Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus. J Am Coll Surg (2001) 1.06
Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique. Int J Radiat Oncol Biol Phys (2000) 1.06
Relationships among protein and albumin concentrations and oncotic pressure in nephrotic plasma. Am J Physiol (1993) 1.05
Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy. Hum Gene Ther (2000) 1.04